thrombolytic agent

1. Conclusion Domestic recombinant streptokinase is an effective, reliable and safe thrombolytic agent.
   结论国产重组链激酶为治疗急性心肌梗塞有效、安全的溶栓药物。
2. Methods: Based upon the specific affinity of hirudin towards thrombin and its precursors, we constructed a fusion gene encoding the protein with a fusion point between the 12 amino acid peptide from the hirudin C terminus and the thrombolytic agent staphylokinase.
   方法：利用水蛭素对血栓及血栓前体特异性亲合的作用特点，构建葡激酶与水蛭素C端12肽的融合基因。
3. Conclusion: China-made r-sk is a safe and effective thrombolytic agent.
   结论：r-sk静脉溶栓再通率高，不良反应少，为一安全有效的溶栓剂。
4. Methods: Twentytwo cases of AMI were treated with huang qi sheng mai powder combined use of thrombolytic agent ( urokinase, UK)( treatment group) and compared to 20 cases of AMI treated with UK alone.
   方法：采用黄芪生脉散结合尿激酶（UK）溶栓治疗AMI患者22例（治疗组），并与20例单用UK溶栓治疗者作对照（对照组）。
5. In early stage of AMI, platelets are in a higher activation status. Thrombolytic agents in combination with potent specific antiplatelet agent will produce a promoted action for thrombolytic therapy.
   在AMI患者溶栓同时联合应用特异性高、效力强的抗血小板药物将对溶栓治疗产生促进作用。
6. OBJECTIVE: To discuss the metabolic characteristics and variation law of hyperacute cerebral infarction so as to provide pathophysiological evidence for thrombolytic therapy and the application of neuro protective agent in hyperacute phase.
   目的：探讨超急性脑梗死的代谢特点及演变规律，为超急性期溶栓治疗和神经保护剂的使用提供病理生理学依据。
7. Development of Plasminogen-Activators as Thrombolytic Agent
   纤溶酶原激活剂类药物的现状和进展
8. Objective To observe the changes of plasma endothelin-renin angiotensin-atrial natriuretic peptide system ( ERAANPS) after acute myocardial infarction ( AMI) and the effects of thrombolytic agent.
   目的观察尿激酶对急性心肌梗死（AMI）患者血浆-内皮素-肾素-血管紧张素-心钠素系统（ERAANPS）的影响。
9. The other objective is to preliminary obtain purified fusion protein as a new thrombolytic agent for clinical application in thrombotic diseases. [ Materials and Methods] The implementation plan of this research was carried out through the following methods and steps. 1.
   本研究的另一目的是为下一步获得初步纯化的融合蛋白，以此作为一种新型溶栓药应用于临床上血栓性疾病的治疗。
10. The remaining 16 patients underwent surgical treatment combined with systemic therapy and were applied with an appropriate amount of vasodilator, anticoagulant and thrombolytic agent for preoperative, intraoperative and postoperative.
    余16例患者接受手术治疗结合全身治疗，术前、术中、术后依具体情况应用适量的扩张剂、抗凝剂、溶栓剂。

noun

1. a kind of pharmaceutical that can break up clots blocking the flow of blood to the heart muscle

   Synonym:    thrombolyticclot buster